International Journal of Clinical Endocrinology and Metabolism
Research Article
Research Article
Glutamic Acid Decarboxylase Autoantibodies Role in Reclassifying Diabetes of Adulthood in Basrah
Aim: To determine the prevalence
and phenotypic characteristics of diabetes subtypes based on glutamic acid
decarboxylase autoantibodies (GADA) status in those newly presented diabetic to
the Al-Faiha Specialized Diabetes, Endocrine and Metabolism Center (FDEMC)
in Basrah, Southern Iraq.
Methods : The study design is
cross-sectional and includes adult diabetic patients if they are free of
insulin treatment for at least 6 months from diagnosis and to be 30 years of
age and over from the period of January 2013 to March 2013.
Results: Of our diabetics with age
30 years and more, 26.4% were GADA-positive. The only significantly higher
variables seen more among GADA-positive diabetes groups were normal weight and
current insulin uses. GADA-positivity was not associated with gender, age, BMI,
family history, smoking, hypertension, duration of diabetes, or specific HbA1c
in the current study.
Conclusion: A quarter of adults
diabetic in Basrah were GADA positive. GADA positivity means more likely to be
normal weight diabetics and currently on insulin use.
http://www.peertechz.com/Clinical-Endocrinology-Metabolism/pdf/IJCEM-1-104.pdf
Comments
Post a Comment